Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • DXCM vs MRNA✓SelectedUSD · MRNADXCM vs MRNA performance historyLatest closeAs of-2.06%11/16
Stock and ETF performance explorer

DXCM vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+168.9%
MRNA return
+878.5%
Excess return
-709.6%
Maximum drawdown
-66.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.1%-3.6%+1.6%-1.8%
7D+0.7%-20.0%+20.6%+2.1%
30D-5.1%-1.3%-3.9%-5.3%
3M-9.1%+240.0%-249.0%-21.1%
6M+32.4%+339.0%-306.5%+10.4%
YTD+23.0%+630.0%-607.0%-4.2%
1Y+40.6%+769.1%-728.5%+7.0%
3Y-22.1%+181.2%-203.3%-35.9%
5Y-49.6%-8.1%-41.5%-54.6%
All+168.9%+878.5%-709.6%+107.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling